Coronary Artery Disease (CAD)

ART-ASPI CATHETER-01 study is an observational, prospective, post-market, single arm, open label, multicentre study. Within this trial, 60 patients are planned to be enrolled. During the trial, clinical data will be collected and evaluated from the use of the aspiration catheter during percutaneous...

The European Bifurcation Club randomized trial of stepwise provisional stenting versus Drug Coated Balloon Therapy for non-left main true coronary bifurcations Legal Representative of Sponsor in European Union: CERC Investigator Initiated Trial The EBC DCB study is an investigator initiated, multi...

The INFINITY-SWEDEHEART trial is a prospective, multicenter, single-blind, randomized registry-based clinical trial. Eligible patients will be randomized 1:1 (DynamX Bioadaptor: Resolute Onyx) The INFINITY-SWEDEHEART study will evaluate the safety and effectiveness of the DynamX Bioadaptor compared...

Nagomi Complex PMCF is a Post-Market Clinical Follow-up Study with Ultimaster NagomiTM Sirolimus Eluting Coronary Stent System in Complex PCI Subjects 3,000 Complex subjects eligible for a percutaneous coronary intervention are enrolled in the study. Quantitative Coronary Angiography (QCA) will be...

The DESyne BDS Plus Randomised Clinical Trial (RCT) will seek to evaluate the safety, effectiveness and performance of the DESyne BDS Plus DECSS (Test) as compared to the CE Mark approved DESyne X2 Novolimus Eluting Coronary Stent System (DESyne X2 NECSS; DESyne X2) (Control) in the treatment of de...